0
0
Read Time:11 Second
The move by Swiss multi-national, Roche (F. Hoffmann-la Roche AG), seeking permanent injunction to prevent the introduction of a generic drug for Spinal Muscular Atrophy (SMA) jeopardises public interest by limiting access to affordable medication,…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %